Learning outcomes
Training description
The focus of this two days training will be on providing an update of ongoing activities regarding medicines’ risk and signal management. The first day will be an opportunity to provide the participants practical advice on RMP drafting and preparation as well the accessors point of view in evaluating an RMP. Moreover, the increasing number of biosimilars and biologicals being authorized highlighted a need to better streamline the safety specification for these products so that only risks that are important for risk management and relevant for the benefit-risk of the product are included in the RMP. Also, a dedicated section on the risk management aspects of the new GVP guidance on special populations such as children and elderly will be provided.
On the second day participants will have the opportunity to get an insight on the current signal detection and management guidelines and tools, as also on the EMA pilot phase using Eudravigilance Data Analysis System (EVDAS). Regarding signal management using EVDAS, a pilot phase including a limited number of active substances selected based on the list of medicinal products subject to additional monitoring is currently ongoing. During the signal management session, pragmatic approaches, lessons learned, as also processes for signal management and eRMR assessment will be discussed. Finally, during this training, an outlook of current and future challenges in pharmacovigilance focusing on the impact of the coming into force of the General Data Protection (GDPR) Regulation in May 2018 will be given and discussed.
Training schedule
Day one
09:00 EU guidelines on risk management: some background
10:00 RMP structure and compilation
11:00 Break
11:15 Assessing RMPs and RMP quality indicators
12:15 Effective risk communication (HA, patient and MAH perspectives)
13:00 Lunch Break
14:00 Handling of Risk Minimization measures
14:45 RMP for Biosimilars and biologicals
15:30 Break
15:45 RMP for special populations (pediatrics, elderly and pregnant women)
17:00 End of day 1
Day two
09:00 EU Guidelines on Signal Management-background
10:00 Authorities expectation on Signal management
11:00 Break
11:15 Signal management and inspections
12:15 Performing Signal Detection (examples and best practices)
13:00 Lunch Break
14:00 Data mining using regulatory databases
14:45 Signal detection in EVDAS (eRMR analysis, generis and innovative products)
15:30 Break
15:45 MAH experience in EVDAS (lessons learned)
16:45 GDPR in Pharmacovigilance-what is new for MAHs?
17:30 End of day 2
Training Program
Get insight into a similar past event
Get to know the Expert Trainer
Dimitris Zampatis, MSc, PhD, is an Associate Director, Signal and Risk Management Process at Merck Biopharma. He holds a BSc in Biology, a MSc in Medicinal Chemistry: Drug Design and Development and a PhD in Cell and Molecular Biology.
In his current role he is responsible for the development of the company’s benefit-risk assessment framework, the signal detection strategy e.g. quantitative and qualitative signal detection methods using internal and external databases (EVDAS, VigiBase, FAERS, VAERS, JADER) as also the Risk Management and risk minimization measures processes and implementation.
Through his career Dimitris gained substantial knowledge and experience in different aspects of Drug Safety and Pharmacovigilance such as Signal Detection, RMPs, PBRERs/PSURs, DSURs, safety communication (e.g. Direct Healthcare Professional Communication/Dear Investigator Letter). He participated in various successful FDA and EMA submission applications either as a team member or as team leader.
Dimitris is also a Pharmacovigilance tutor and trainer and participates in various conferences as
a speaker.
Who should attend?
• Individuals involved in risk management planning, risk minimisation development and post authorisation safety studies at small to medium enterprises (SMEs), MAAs / MAHs for generic products, MAAs / MAHs for innovator products and Contract Research Organisations (CROs)
• Risk communication experts
• Qualified Persons responsible for Pharmacovigilance (QPPVs)
• Individuals involved in pharmacovigilance, safety database, signal management and information management
All in one event platform powered by:
Our Past Media Partners
Our events were attended by these companies
FAQ
The client has the right to cancel his/her registration in the event.
There is a 50% liability on all conference registrations once made, whether the booking was made through our website or via e–mail/ telephone/ fax.
If the client cancels with more than 8 weeks’s advance notice, GLC shall be entitled to an amount equivalent to 50% of the conference fee and 16 EUR administration charge. In case the client has already made his/her payment, this will be deducted from the conference fee GLC has already received and the remainder will be refunded. If no conference fee has been received prior to the cancellation request, GLC will issue an invoice for the cancellation fee (the amount equivalent to 50% of the conference fee and 16 EUR administration charge), which the client must pay immediately upon receipt. No refunds are available for cancellations received with 8 week’s (or less) advance notice or in case the client fails to attend the conference. In these cases, the full amount of the conference fee must be paid.
- Get the timing right.
Many people are afraid to request for training budget, because they can’t seem to find the “perfect time” to do it. Well, there’s no perfect time to ask for it, but there are definitely some moments that are better than others. For instance, if your boss is about to take a two week vacation, he/she might be in a good mood. If he/she just lost a major account, may not be wise at that juncture. - Make a case for yourself
When you ask for budget, you should be prepared with specific details and explanations about what is in it for the company and you’re superior. If you go into a meeting and just say, “I want to get budget for a conference,” it’s likely that your request won’t be taken seriously. If you want to plan ahead, then you should be prepared to explain the following points:
1. Start by stating your accomplishments
2. Show that you’re ready for more responsibility and eager to learn
3. Describe:
a) How this event will increase your productivity?
b) How you will need less supervision
c) How you can bring back the knowledge to the company
4. Follow up